Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs

 

To work with official State and territorial health agencies or their designees, and tribal health agencies in developing comprehensive breast and cervical cancer early detection programs. To the extent possible, increase screening and follow-up among all groups of women in the State, tribe or territory, with special to reach those women who are of low income, uninsured, underinsured and minority, and Native Americans.

Deleted 03/27/2024 (Archived.) 93.919 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Breast and Cervical Cancer Mortality Prevention Act of 1990, Section 301(a), Section 317(k)(3), and Section 1501, Public Law 101-354; 42 U.S.C.241a, 42 U.S.C. 247b(k)(3), and 42 U.S.C. 300K; Public Law 103-183, Public Law 101-354, 42 U.S.C. 241,247,300 Eligible applicants are the official State health agencies of the United States, the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, Guam, the Northern Mariana Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, American Samoa, American Indian and Alaska Native tribes and tribal organizations as defined in Section 4 of the Indian Self-Determination and Education Assistance Act. Official State and Territorial health agencies, women especially low-income women. Applicants should document the need for assistance, state the objectives of the project, outline the method of operation, describe evaluation procedures, identify and describe nonfederal contributions, and provide a budget with justification for funds requested. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Information on the submission of applications may be obtained from Ms. Shicann Phillips, Grants Management Specialist, in the Grants Management Branch, Procurement and Grants Office, Centers for Disease Control and Prevention, Atlanta, Georgia 30341. Telephone: (770) 488-2615. This program is subject to the provisions of 45 CFR 92 for State and local governments. The standard application forms, as furnished by PHS and required by 45 CFR 92 must be used for this program. In the competitive year one and after objective review and approval, a notice of award is prepared and processed, along with appropriate notification to the public. For non-competitive continuation years, after review and approval on the Interim Progress Report (IPR), a notice of award is prepared and processed, along with appropriate notification to the public. Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. From 3 to 4 months. Not applicable. Information on renewals may be obtained from Pamela Render, Grants Management, Office of Grants Services, Office of Financial Resources Centers for Disease Control and Prevention, Atlanta, GA 30341; Telephone: (770) 488-2712. (1) Extent of disease burden and need; (2) feasibility and appropriateness of operational plan to meet the purpose of the cooperative agreement; (3) the extent of collaboration and community involvement; (4) the extent to which the applicant appears likely to succeed in implementing proposed objectives; (5) the appropriateness of nonfederal contributions; and (6) the extent to which the budget is reasonable, consistent with the intended use of cooperative agreement funds, and includes evidence of the State's commitment to the program application of financial and/or in-kind contributions from nonfederal sources to activities of the proposed program. Cooperative agreements funds may be used to assure screening of women for breast and cervical cancer as an early detection preventive measure; assure appropriate referrals for follow-up services for women with abnormal screening tests and routine rescreening; develop and disseminate public education and outreach programs for the early detection and control of breast and cervical cancers; improve the education, training and skills of health professionals (including allied health professionals) in the early detection and control of breast and cervical cancers; establish mechanisms through which the States, tribes and territories can monitor the quality of breast and cervical cancer screening procedures in the State, including the interpretation of such procedures; and evaluate program activities through appropriate surveillance and monitoring. Cooperative agreement funds may not be expended for screening and follow-up services to the extent that payment has been made, or can reasonably be expected to be made, with respect to such items or services: (1) under any State compensation program, under any insurance policy or under any Federal or State health benefits program; or (2) by any entity that provides health services on a prepaid basis. Cooperative agreement funds shall not be used for treatment or treatment services. States, tribes and territories are required to make available nonfederal contributions in cash or in-kind toward such cost in an amount equal to not less than $1 for each $3 of Federal funds provided. Such contributions may be made directly or through donations from public or private entities. The payment for treatment services or the donation of treatment service may not be used for nonfederal contributions. States, tribes and territories may include only nonfederal contributions in excess of the average amount of nonfederal contributions made by the State, tribe or territory for the two year period preceding the first fiscal year for which the State, tribe or territory is applying to receive a cooperative agreement for a comprehensive breast and cervical cancer early detection program. In making a determination of the amount of nonfederal contributions for purposes of matching fund requirements, applicants may include any nonfederal amounts expended pursuant to Title XIX of the Social Security Act for the purpose of screening and follow- up for women at-risk for breast and cervical cancers. Performance Reports: Final FFR and Final Progress Report are due 90 days after the end of the project period. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. Financial records, supporting documents, statistical records, and all other records pertinent to the cooperative agreement program shall be retained for a minimum of three years, or until completion and resolution of any audit in process or pending resolution. In all cases, records must be retained in accordance with PHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching is voluntary. 35%. Public Law 101-354 requires States, tribes and territories to make available nonfederal contributions (cash or in-kind) toward such costs in an amount equal to not less than $1 of matching for every $3 of Federal dollars provided in this cooperative agreement. Such contributions may be made directly or through donations from public or private entities. Payment for treatment services or the donation of treatment services may not be used for nonfederal contributions. States, tribes and territories may include only nonfederal contribution in excess of the average amount of nonfederal contributions made by the State, tribe territory for the two year period preceding the first fiscal year for which the State, tribe or territory is applying to receive a cooperative agreement for a comprehensive Breast and cervical cancer early detection program.

This program has MOE requirements, see funding agency for further details. Additional Information: The average amount of non-Federal contributions toward breast and cervical cancer programs and activities for the two year period preceding the first Federal fiscal year of funding for NBCCEDP is referred to as Maintenance of Effort (MOE). Only those non-Federal contributions in excess of the MOE amount may be considered matching funds. Supplanting, or replacing, existing program efforts currently paid with Federal or non-Federal sources is not allowable. From 1 to 5 years. Budget period is 12 months. Assistance is awarded through the Payment Management System (PMS). Method of awarding/releasing assistance: Lump. None/Not specified. Faye L Wong,
4770 Buford Highway, Mailstop F76
Atlanta, GA 30341 US
FWong@cdc.gov
Phone: (770) 488-4880
Fax: (770) 488-3230. http://www.cdc.gov/cancer. 75-0943-0-1-550 (Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$0.00; FY 16$213,282,518.00; - In FY17, this project was re-competed under DP17-1701. Project end date was 6/29/2017. In FY15, NBCCEDP was partially funded by PPHF funds ($97,834,313) (Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; - 96,735 to 9,692,758; $2,234,163 There are no regulations, but guidelines are available. PHS Grants Policy Statement, DHHS Publication No. (OASH) 94-50,000, applies to cooperative agreements. Public Law 101-354 (August 10, 1994) places specific requirements on monies from this law which are to be used for funding State-based breast and cervical cancer early detection programs. Fiscal Year 2016 At this time, it is assumed that grantees will continue to provide screening and follow-up for low income women, State health agencies will incorporate into their health care system: (1) Public Education: (a) population targeted for screening and follow-up services; (b) for women (other than low income) requiring periodic screening and follow up services; (2) Professional Education: (a) practitioners providing screening and follow-up services for targeted low income women; (b) for all practitioners who will provide or refer women (other than low income) for required periodic screening and follow-up services (3) quality assurance: (a) mammography; (b) cervical cytology; (4) surveillance: (a) breast and cervical cancer incidence registry; (b) tracking and follow-up system; (5) evaluation: (a) implementation of all program components; (b) effectiveness of all program components; and (6) breast and cervical cancer control plan and coalition. At this time, it is assumed that grantees will continue to provide screening and follow-up for low income women, State health agencies will incorporate into their health care system: (1) Public Education: (a) population targeted for screening and follow-up services; (b) for women (other than low income) requiring periodic screening and follow up services; (2) Professional Education: (a) practitioners providing screening and follow-up services for targeted low income women; (b) for all practitioners who will provide or refer women (other than low income) for required periodic screening and follow-up services (3) quality assurance: (a) mammography; (b) cervical cytology; (4) surveillance: (a) breast and cervical cancer incidence registry; (b) tracking and follow-up system; (5) evaluation: (a) implementation of all program components; (b) effectiveness of all program components; and (6) breast and cervical cancer control plan and coalition.
Fiscal Year 2017 This project ended 6/29/2017
Fiscal Year 2018 This project ended 6/29/2017